The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
CD133 Is Essential for Glioblastoma Stem Cell Maintenance
Abstract
The role of the cell surface CD133 as a cancer stem cell marker in glioblastoma (GBM) has been widely investigated, since it identifies cells that are able to initiate neurosphere growth and form heterogeneous tumors when transplanted in immune-compromised mice. However, evidences of CD133-negative cells exhibiting similar properties have also been reported. Moreover, the functional role of CD133 in cancer stem/progenitor cells remains poorly understood. We studied the biological effects of CD133 downregulation in GBM patient-derived neurospheres. Our results indicate that there is not a hierarchical relation between CD133-positive and CD133-negative cells composing the neurospheres. Indeed, CD133 appears in an interconvertible state, changing its subcellular localization between the cytoplasm and the plasmamembrane of neurosphere cells. Silencing of CD133 in human GBM neurospheres using lentivirus-mediated short hairpin RNA impairs the self-renewal and tumorigenic capacity of neurosphere cells. These results imply that CD133 could be used as a therapeutic target in GBMs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., & Vescovi, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,311
Direct isolation of human central nervous system stem cells
Uchida, N., Buck, D. W., He, D., Reitsma, M. J., Masek, M., Phan, T. V., Tsukamoto, A. S., Gage, F. H., & Weissman, I. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14720 · Cited by 1,849
AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells
Yin, A. H., Miraglia, S., Zanjani, E. D., Almeida-Porada, G., Ogawa, M., Leary, A. G., Olweus, J., Kearney, J., & Buck, D. W. (1997) · Blood · doi:10.1182/blood.v90.12.5002 · Cited by 1,822
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Piccirillo, S. G. M., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., & Vescovi, A. L. (2006) · Nature · doi:10.1038/nature05349 · Cited by 1,176
Self-citationBeier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P. J., Aigner, L., Brawanski, A., Bogdahn, U., & Beier, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4180 · Cited by 1,153
Miraglia, S., Godfrey, W., Yin, A. H., Atkins, K., Warnke, R., Holden, J. T., Bray, R. A., Waller, E. K., & Buck, D. W. (1997) · Blood · doi:10.1182/blood.v90.12.5013 · Cited by 984
SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
Son, M. J., Woolard, K., Nam, D.-H., Lee, J., & Fine, H. A. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.003 · Cited by 672
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
Wang, J., Sakariassen, P. Ø., Tsinkalovsky, O., Immervoll, H., Bøe, S. O., Svendsen, A., Prestegarden, L., Røsland, G., Thorsen, F., Stuhr, L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23130 · Cited by 567
A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in Glioblastoma
Chen, R., Nishimura, M. C., Bumbaca, S. M., Kharbanda, S., Forrest, W. F., Kasman, I. M., Greve, J. M., Soriano, R. H., Gilmour, L. L., Rivers, C. S., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.049 · Cited by 544
Günther, H. S., Schmidt, N. O., Phillips, H. S., Kemming, D., Kharbanda, S., Soriano, R., Modrusan, Z., Meissner, H., Westphal, M., & Lamszus, K. (2008) · Oncogene · doi:10.1038/sj.onc.1210949 · Cited by 443
IDENTIFICATION OF A2B5+CD133− TUMOR-INITIATING CELLS IN ADULT HUMAN GLIOMAS
Ogden, A. T., Waziri, A. E., Lochhead, R. A., Fusco, D., Lopez, K., Ellis, J. A., Kang, J., Assanah, M., McKhann, G. M., Sisti, M. B., et al. (2008) · Neurosurgery · doi:10.1227/01.neu.0000316019.28421.95 · Cited by 408
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
Joo, K. M., Kim, S. Y., Jin, X., Song, S. Y., Kong, D.-S., Lee, J.-I., Jeon, J. W., Kim, M. H., Kang, B. G., Jung, Y., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.57 · Cited by 337
CD133 Is a Marker of Bioenergetic Stress in Human Glioma
Griguer, C. E., Oliva, C. R., Gobin, E., Marcorelles, P., Benos, D. J., Lancaster, J. R., & Gillespie, G. Y. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003655 · Cited by 247
Rappa, G., Fodstad, O., & Lorico, A. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0601 · Cited by 234
Neural Stem Cell Isolation and Characterization
Rietze, R. L., & Reynolds, B. A. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)19001-1 · Cited by 222
Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
Immervoll, H., Hoem, D., Sakariassen, P. Ø., Steffensen, O. J., & Molven, A. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-48 · Cited by 206
Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation
Mak, A. B., Nixon, A. M. L., Kittanakom, S., Stewart, J. M., Chen, G. I., Curak, J., Gingras, A.-C., Mazitschek, R., Neel, B. G., Stagljar, I., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.016 · Cited by 183
CD133 (Prominin) Negative Human Neural Stem Cells Are Clonogenic and Tripotent
Sun, Y., Kong, W., Falk, A., Jin, H., Zhou, L., Pollard, S. M., & Smith, A. G. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005498 · Cited by 138
Bauer, N., Wilsch‐Bräuninger, M., Karbanová, J., Fonseca, A., Strauss, D., Freund, D., Thiele, C., Huttner, W. Β., Bornhäuser, M., & Corbeil, D. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100147 · Cited by 115
Elsaba, T. M., Martínez‐Pomares, L., Robins, A., Crook, S., Seth, R., Jackson, D., Reed, A. E. M., Silver, A. R., Tomlinson, I. P. M., & Ilyas, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010714 · Cited by 104
Current Strategies for Identification of Glioma Stem Cells: Adequate or Unsatisfactory?
Brescia, P., Richichi, C., & Pelicci, G. (2012) · Journal of Oncology · doi:10.1155/2012/376894 · Cited by 94
Self-citationVik-Mo, E. O., Sandberg, C. J., Ølstørn, H., Varghese, M., Brandal, P., Ramm‐Pettersen, J., Murrell, W. G., & Langmoen, I. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq102 · Cited by 63
Expression and regulation of AC133 and CD133 in glioblastoma
Campos, B., Zeng, L., DaoTrong, P. H., Eckstein, V., Unterberg, A. W., Mairbäurl, H., & Herold‐Mende, C. C. (2011) · Glia · doi:10.1002/glia.21239 · Cited by 48
Rai is a New Regulator of Neural Progenitor Migration and Glioblastoma Invasion
Ortensi, B., Osti, D., Pellegatta, S., Pisati, F., Brescia, P., Fornasari, L., Levi, D., Gaetani, P., Colombo, P., Ferri, L., et al. (2012) · Stem Cells · doi:10.1002/stem.1056 · Cited by 36
Self-citationRapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo
Peickert, S., Waurig, J., Dittfeld, C., Dietrich, A., Garbe, Y., Kabus, L., Baumann, M. A., Grade, M., Ried, T., & Kunz‐Schughart, L. A. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.124 · Cited by 17
Cited by
Understanding and targeting cancer stem cells: therapeutic implications and challenges
Chen, K., Huang, Y.-H., & Chen, J.-L. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.27 · Cited by 608
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
Emerging treatment strategies for glioblastoma multiforme
Carlsson, S. K., Brothers, S. P., & Wahlestedt, C. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201302627 · Cited by 365
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances
Xue, C., Chu, Q., Shi, Q., Zeng, Y., Lu, J., & Li, L. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02142-w · Cited by 281
Helweg, L. P., Storm, J., Witte, K. E., Schulten, W., Wrachtrup, L., Janotte, T., Kitke, A., Greiner, J. F. W., Knabbe, C., Kaltschmidt, B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112919 · Cited by 10
Metadata
- Authors
- Brescia, P., Ortensi, B., Fornasari, L., Levi, D., Broggi, G., & Pelicci, G.
- Venue
- Stem Cells
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-04-24
- Volume
- 31
- Issue
- 5
- Pages
- 857-869
- ISSN
- 1066-5099 (ISSN-L)
- 1549-4918
- OpenAlex
- W2090057452
- Cited by
- 254
- References
- 28
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
